0001104659-16-145488.txt : 20161020 0001104659-16-145488.hdr.sgml : 20161020 20160919171135 ACCESSION NUMBER: 0001104659-16-145488 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SteadyMed Ltd. CENTRAL INDEX KEY: 0001619087 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 5 OPPENHEIMER STREET CITY: REHOVOT STATE: L3 ZIP: 76701 BUSINESS PHONE: (925) 272-4991 MAIL ADDRESS: STREET 1: 5 OPPENHEIMER STREET CITY: REHOVOT STATE: L3 ZIP: 76701 CORRESP 1 filename1.htm

 

SteadyMed Ltd.

2603 Camino Ramon, Suite 350,

San Ramon, California 94583

 

September 19, 2016

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

Attn:                    Suzanne Hayes

Jeffrey Gabor

 

Re:                             SteadyMed Ltd.

Form S-3 Registration Statement

Registration File No. 333-213494

 

Acceleration Request

Requested Date:      September 21, 2016

Requested Time:  4:00 P.M. Eastern Time

 

Ladies and Gentlemen:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on Wednesday, September 21, 2016, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Michael Tenta of Cooley LLP, counsel to the Registrant, at (650) 843-5636, or in his absence, Rose Standifer of Cooley LLP at (650) 843-5732.

 

In connection with this request, the undersigned registrant hereby acknowledges that:

 

(i)                                     should the Commission or the staff of the Commission (the “Staff”), acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Filing;

 

(ii)                                  the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and the accuracy of the disclosure in the filing; and

 

(iii)                               the Registrant may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

Very truly yours,

 

 

 

SteadyMed Ltd.

 

 

 

 

 

/s/ David W. Nassif

 

David W. Nassif

 

Chief Financial Officer

 

 

 

 

 

cc:

Jonathan Rigby, SteadyMed Ltd.

 

 

Michael Tenta, Cooley LLP

 

 

Rose Standifer, Cooley LLP